| Elmer F. Baysa Md, Inc | |
|
91-775 Papipi Rd Ste A Ewa Beach HI 96706-2466 | |
| (808) 689-8315 | |
| (808) 689-8153 |
| Full Name | Elmer F. Baysa Md, Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 91-775 Papipi Rd Ste A, Ewa Beach, Hawaii |
| Authorized Official Name and Position | Malia Valencia (OFFICE MANAGER) |
| Authorized Official Contact | 8086898315 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Elmer F. Baysa Md, Inc 91-775 Papipi Rd Ste A Ewa Beach HI 96706-2466 Ph: (808) 689-8315 | Elmer F. Baysa Md, Inc 91-775 Papipi Rd Ste A Ewa Beach HI 96706-2466 Ph: (808) 689-8315 |
| NPI Number | 1619456035 |
|---|---|
| Provider Enumeration Date | 08/07/2018 |
| Last Update Date | 08/07/2018 |
| Medicare PECOS PAC ID | 0749538601 |
|---|---|
| Medicare Enrollment ID | O20180808003654 |
News Archive
The Global Alliance for TB Drug Development and Drugs for Neglected Diseases initiative announced today a unique first-ever royalty-free license agreement between two not-for-profit drug developers that speeds progress toward markedly improved therapy of multiple neglected diseases. The TB Alliance has granted rights to DNDi to develop a class of potential anti-TB compounds that also show significant promise for treating other neglected diseases that largely affect the world's poor.
Scientists from the Broad Institute of Harvard and MIT, Lund University and Novartis have announced the discovery of three unsuspected regions of human DNA that contain clear genetic risk factors for type 2 diabetes, and another that is associated with elevated blood triglycerides.
StockPreacher.com announces an investment report featuring Sunesis Pharmaceuticals Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement today on a new Government Accountability Office (GAO) report, "Medicare Part D Formularies: CMS Conducts Oversight of Mid-Year Changes; Most Mid-Year Changes Were Enhancements":
A particular tumor suppressor gene that fights cancer cells does more than clamp down on unabated cell division - the hallmark of the disease - it also can help make cells more fit by allowing them to fend off stress, says a University of Colorado Boulder study.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619456035 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD-4889 (Hawaii) | Primary |
| Provider Name | Elmer F Baysa |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1699829127 PECOS PAC ID: 1254366628 Enrollment ID: I20051004001118 |
News Archive
The Global Alliance for TB Drug Development and Drugs for Neglected Diseases initiative announced today a unique first-ever royalty-free license agreement between two not-for-profit drug developers that speeds progress toward markedly improved therapy of multiple neglected diseases. The TB Alliance has granted rights to DNDi to develop a class of potential anti-TB compounds that also show significant promise for treating other neglected diseases that largely affect the world's poor.
Scientists from the Broad Institute of Harvard and MIT, Lund University and Novartis have announced the discovery of three unsuspected regions of human DNA that contain clear genetic risk factors for type 2 diabetes, and another that is associated with elevated blood triglycerides.
StockPreacher.com announces an investment report featuring Sunesis Pharmaceuticals Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement today on a new Government Accountability Office (GAO) report, "Medicare Part D Formularies: CMS Conducts Oversight of Mid-Year Changes; Most Mid-Year Changes Were Enhancements":
A particular tumor suppressor gene that fights cancer cells does more than clamp down on unabated cell division - the hallmark of the disease - it also can help make cells more fit by allowing them to fend off stress, says a University of Colorado Boulder study.
› Verified 5 days ago
News Archive
The Global Alliance for TB Drug Development and Drugs for Neglected Diseases initiative announced today a unique first-ever royalty-free license agreement between two not-for-profit drug developers that speeds progress toward markedly improved therapy of multiple neglected diseases. The TB Alliance has granted rights to DNDi to develop a class of potential anti-TB compounds that also show significant promise for treating other neglected diseases that largely affect the world's poor.
Scientists from the Broad Institute of Harvard and MIT, Lund University and Novartis have announced the discovery of three unsuspected regions of human DNA that contain clear genetic risk factors for type 2 diabetes, and another that is associated with elevated blood triglycerides.
StockPreacher.com announces an investment report featuring Sunesis Pharmaceuticals Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement today on a new Government Accountability Office (GAO) report, "Medicare Part D Formularies: CMS Conducts Oversight of Mid-Year Changes; Most Mid-Year Changes Were Enhancements":
A particular tumor suppressor gene that fights cancer cells does more than clamp down on unabated cell division - the hallmark of the disease - it also can help make cells more fit by allowing them to fend off stress, says a University of Colorado Boulder study.
› Verified 5 days ago
James M Warner Md Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 91-2141 Fort Weaver Rd, Ewa Beach, HI 96706 Phone: 808-678-7370 Fax: 808-678-7240 | |
Drt Medical Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 91-2141 Fort Weaver Rd, Ewa Beach, HI 96706 Phone: 808-678-7000 | |
Empower Health Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 91-6390 Kapolei Pkwy, Ewa Beach, HI 96706 Phone: 808-691-4600 | |
Access Medical Clinics Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 91-1401 Fort Weaver Rd, Ewa Beach, HI 96706 Phone: 808-285-2448 | |
West Oahu Acupuncture And Integrative Medicine Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 91-1123 Keaunui Dr Ste 223, Ewa Beach, HI 96706 Phone: 808-638-4559 Fax: 781-998-2412 | |
Waianae District Comprehensive Health And Hospital Board, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 91-1841 Fort Weaver Rd, Ewa Beach, HI 96706 Phone: 808-697-3300 | |
Rachel Tortolini Md,llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 91-896 Makule Rd Ste 102, Ewa Beach, HI 96706 Phone: 808-689-4414 Fax: 808-689-7115 |